UCL 2077
SIGMA/U6758 - ≥98% (HPLC), solid
Synonym: (3-
CAS Number: 918311-87-2
Empirical Formula (Hill Notation): C25H22N2
Molecular Weight: 350.46
MDL Number: MFCD00585879
Linear Formula: C25H22N2
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white |
form | solid |
InChI | 1S/C25H22N2/c1-4-12-22(13 |
InChI key | PQFNWDHABGBCHB-UHFFFAOYSA |
Quality Level | 100 |
SMILES string | C(NC(c1ccccc1)(c2ccccc2)c |
solubility | DMSO: soluble >20 mg/mL |
H2O: insoluble |
Application: | UCL 2077 has been used for slow afterhyperpolarization (sAHP) studies in thalamic paraventricular nucleus (PVT) neurons. UCL 2077 has also been used for studying its effects on the increase in excitability of hippocampal pyramidal cells. |
Biochem/physiol Actions: | UCL 2077 is a slow afterhyperpolarization (sAHP) channel blocker. |
Packaging: | 5, 25 mg in glass bottle |
Preparation Note: | UCL 2077 is soluble in DMSO at a concentration >20 mg/ml and is insoluble in water. |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H302 - H315 - H319 - H335 |
Precautionary statements | P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
Hazard Codes | Xn |
Risk Statements | 22-36/37/38 |
Safety Statements | 26 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
UNSPSC | 12352200 |